From the Departamento de Fisiología, Facultad de Medicina, Murcia,
Spain (J.D.G., M.T.L., E.N., F.J.S.); and I Clinica Medica, University of
Pisa, Italy (L.G.).
Correspondence to F. Javier Salazar, Departamento de Fisiología, Facultad de Medicina, 30100 Murcia, Spain. E-mail salazar{at}fcu.um.es
AbstractPrevious studies have
reported evidence of an important interaction between nitric oxide (NO)
and prostaglandins in the acute regulation of renal
function. The objective of this study was to determine in conscious
dogs whether the renal effects of the prolonged administration of a
cyclooxygenase inhibitor are enhanced
when NO synthesis is reduced. Meclofenamate infusion (5 µg ·
kg-1 · min-1) during 4 consecutive
days (n=8) elicited a continuous decrease (P<0.05) in
renal blood flow and plasma renin activity and a transitory decrease in
sodium excretion.
NG-Nitro-L-arginine methyl ester
(L-NAME) infusion (5 µg · kg-1 ·
min-1) during 6 days (n=8) produced a significant increase
in arterial pressure and a transitory decrease
(P<0.05) in both renal blood flow and plasma renin
activity. The simultaneous inhibition of NO and
prostaglandin synthesis (n=7) led to an increase in
arterial pressure and a decrease in renal blood flow
similar to those observed during the administration of either L-NAME or
meclofenamate. In contrast, this simultaneous inhibition
produced a decrease in glomerular filtration rate, which
was not observed in the previous groups, and also induced an increase
in renal vascular resistance and a decrease in sodium excretion greater
(P<0.05) than those found during the inhibition of
either NO or prostaglandins. Only a transitory decrease in
plasma renin activity was found during meclofenamate infusion in this
group. The results of this study present new evidence that the
renal vasoconstrictor and antinatriuretic effects
induced by the prolonged infusion of a
cyclooxygenase inhibitor are
significantly enhanced when NO synthesis is reduced. These results
suggest that renal function may be more sensitive to the prolonged
administration of a cyclooxygenase
inhibitor in situations where NO production is
reduced.
© 1998 American Heart Association, Inc.
Scientific Contributions
Role of Nitric Oxide and Prostaglandins in the Long-term Control of Renal Function
Key Words: vasoconstriction nitric oxide prostaglandins sodium plasma renin activity
This article has been cited by other articles:
![]() |
A. Loria, V. Reverte, F. Salazar, F. Saez, M. T. Llinas, and F. J. Salazar Sex and age differences of renal function in rats with reduced ANG II activity during the nephrogenic period Am J Physiol Renal Physiol, August 1, 2007; 293(2): F506 - F510. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Obst, V. Gross, J. Janke, M. Wellner, W. Schneider, and F. C. Luft Pressure Natriuresis in AT2 Receptor-Deficient Mice with L-NAME Hypertension J. Am. Soc. Nephrol., February 1, 2003; 14(2): 303 - 310. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Hocherl, M. C. Kammerl, K. Schumacher, D. Endemann, H. F. Grobecker, and A. Kurtz Role of prostanoids in regulation of the renin-angiotensin-aldosterone system by salt intake Am J Physiol Renal Physiol, August 1, 2002; 283(2): F294 - F301. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. K. A. WIEREMA, A. J. H. M. HOUBEN, A. A. KROON, D. KOSTER, K. V. D. ZANDER, J. M. A. V. ENGELSHOVEN, and P. W. D. LEEUW Nitric Oxide Dependence of Renal Blood Flow in Patients with Renal Artery Stenosis J. Am. Soc. Nephrol., September 1, 2001; 12(9): 1836 - 1843. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. SEELIGER, P. B. PERSSON, W. BOEMKE, G. MOLLENHAUER, B. NAFZ, and H. W. REINHARDT Low-Dose Nitric Oxide Inhibition Produces a Negative Sodium Balance in Conscious Dogs J. Am. Soc. Nephrol., June 1, 2001; 12(6): 1128 - 1136. [Abstract] [Full Text] |
||||
![]() |
M. T. Llinas, F. Rodriguez, C. Moreno, and F. J. Salazar Role of cyclooxygenase-2-derived metabolites and nitric oxide in regulating renal function Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2000; 279(5): R1641 - R1646. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Rodriguez, M. T. Llinas, J. D. Gonzalez, J. Rivera, and F. J. Salazar Renal Changes Induced by a Cyclooxygenase-2 Inhibitor During Normal and Low Sodium Intake Hypertension, August 1, 2000; 36(2): 276 - 281. [Abstract] [Full Text] [PDF] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1998 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |